Literature DB >> 1349073

Non-echogenic nuchal oedema as a marker in trisomy 21 screening.

M Schulte-Vallentin, H Schindler.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1349073     DOI： 10.1016/0140-6736(92)90574-m

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Screening for Down's syndrome.

Authors:  H Cuckle
Journal:  BMJ       Date:  1992-12-12

2.  Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.

Authors:  A F Brady; P P Pandya; B Yuksel; A Greenough; M A Patton; K H Nicolaides
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

3.  Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21.

Authors:  B Brand-Saberi; H H Epperlein; G E Romanos; B Christ
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

Review 4.  First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome.

Authors:  S Shiefa; M Amargandhi; J Bhupendra; S Moulali; T Kristine
Journal:  Indian J Clin Biochem       Date:  2012-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.